Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 19.7B | 20.5B | 20.0B | 19.9B |
Cost of revenue | 4.2B | 4.8B | 4.4B | 4.3B |
Gross profit | 15.5B | 15.7B | 15.6B | 15.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 4.3B | 4.6B | 4.2B | 4.3B |
Operating income | 4.3B | 4.2B | 5.0B | 4.6B |
Non operating interest income | ||||
Income | 180M | 223M | 222M | 268M |
Expense | 956M | 1.1B | 1.1B | 1.1B |
Other income expense | — | — | — | — |
Pretax income | 3.8B | 3.1B | 4.7B | 4.2B |
Tax provision | 1.1B | 866M | 1.3B | 1.1B |
Net income | 2.5B | 2.1B | 3.6B | 3.0B |
Basic EPS | 1.6 | 1.3 | 2.4 | 1.8 |
Diluted EPS | 1.6 | 1.3 | 2.4 | 1.8 |
Basic average shares | 1.4B | 1.4B | 1.4B | 1.4B |
Diluted average shares | 1.4B | 1.4B | 1.4B | 1.4B |
EBITDA | 9.7B | 9.1B | 9.4B | 9.3B |
Net income from continuing op. | 3.6B | 2.9B | 4.9B | 4.1B |
Minority interests | -328M | -319M | -374M | -439M |
Preferred stock dividends | 0 | 0 | 0 | 0 |